The diplomatic stand-off between India and Canada is unlikely to have any impact on the pharmaceutical exports, according to R Uday Bhaskar, Director-General, Pharmaceutical...
Chennai-based Caplin Point Laboratories has earmarked ₹500-550 crore towards capital expenditure (capex). It includes expansion of existing capacities, additional manufacturing sites to widen...
